Pharma Excipients

News on Pharma Excipients

The Potential for a Ban on TiO2 (E171) use in Pharmaceuticals

POTENTIAL TiO2 BAN STATUS AND IMPLICATIONS The EU considers banning TiO2 in pharmaceuticals, potentially impacting over 91,000 drug products and causing shortages. Titanium dioxide, also known as E171 or TiO2, has long been used across the cosmetics, medicine, and food industries without safety concerns. The EU has recently imposed a ban on the…

Polymeric Nanohydrogel in Topical Drug Delivery System

Nanohydrogels (NH) are biodegradable polymers that have been extensively studied and utilized for various biomedical applications. Drugs in a topical medication are absorbed via the skin and carried to the intended location, where they are…

Skin-friendly textures – by Gattefossé

Caring for patients Patient preferences and needs as well as therapeutic indication should be considered at early stage of development of topical or transdermal formulations. To increase adherence to skin treatments, it is important…

Roquette signs agreement to acquire IFF Pharma Solutions

La Madeleine (France), 19 March 2024 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients, announced today an agreement to acquire IFF Pharma Solutions, a worldwide producer of excipients for oral dosage…